Matches 1 - 50 out of 116 1 2 3 >
Match Document Document Title
7622482 Chemical compounds  
This invention relates to novel compounds having the formula (I): and to their pharmaceutical compositions and to their methods of use. These novel compounds provide a treatment for cancer.
7589097 Triazol[4,5-d] pyramidine derivatives and their use as purinergic receptor antagonists  
The use of a compound of formula (I): wherein R 1 is selected from H, alkyl, aryl, alkoxy, aryloxy, alkylthio, arylthio, halogen, CN, NR 5 R 6 , NR 4 COR 5 , NR 4 CONR 5 R 6 , NR 4 CO 2 R 7 ...
7566722 Triazolopyrimidine derivatives as ADP P2Y12 receptor antagonists  
The present invention is directed to novel bicyclic triazolopyrimidine compounds of Formula (I) or a form thereof: wherein R 1 and R 2 are as defined herein, and their methods of preparation...
7563781 Triazolopyrimidine derivatives  
The invention relates to the discovery of triazolopyrimidine derivatives of formula (I), which have been found to exhibit inhibitory activity against the serine-tyrosine and tyrosine kinases.
7560458 Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors  
This invention concerns compounds of formula N-oxides, pharmaceutically acceptable addition salts, quaternary amines and stereochemically isomeric forms thereof, their use, pharmaceutical...
7407962 Heteroaryl compounds useful as inhibitors or protein kinases  
The present invention provides compounds that are inhibitors of protein kinase, particularly inhibitors of ERK2, GSK3, PKA, CDK2 protein kinases, mammalian protein kinases involved in proliferative...
7345047 Substituted [1,2,3]triazolo[4,5-d]pyrimidines  
The invention provides novel substituted cyclopentane compounds (in particular, substituted [1,2,3]triazolo[4,5-d]pyrimidines), their use as medicaments (in particular, their use as anti-thrombotic...
7339058 Process for the preparation of N-([1,2,4]triazolopyrimidin-2-yl)aryl sulfonamides  
The N-arylsulfilimine-catalyzed coupling of aromatic sulfonyl chlorides with N-([1,2,4]triazolopyrimidin-2-yl)amines to form N-([1,2,4]triazolo-pyrimidin-2-yl)aryl sulfonamides is improved by the...
7265124 Cristalline and amorphous form of a triazolo (4,5-D) pyridimine compound  
The invention provides new forms of a chemical compound of formula (I). The invention relates to forms of a chemical compound (I), in particular to crystalline and amorphous forms, more...
7250419 Trisubstituted triazolopyrimidines for use in platelet aggregation inhibition  
The invention provides new triazolo[4,5-d]pyrimidine compounds, their use as medicaments, compositions containing them and processes for their preparation.
7129244 Triazolopyrimidines and related analogs as HSP90-inhibitors  
A compound represented by Formula I, or a polymorph, ester, tautomer, enantiomer, diastereomer, pharmaceutically acceptable salt or prodrug thereof, Wherein R 1 is halogen, —OR 11 , —SR 11...
7115739 Triazole compounds useful as protein kinase inhibitors  
This invention describes novel triazole compounds of formula IX: wherein Z 1 is nitrogen or CR 9 and Z 2 is nitrogen or CH, provided that at least one of Z 1 and Z 2 is nitrogen; G is Ring...
7074929 Certain alkylene diamine-substituted heterocycles  
This invention relates to novel compounds, compositions, and methods for the treatment of physiological disorders associated with an excess of neuropeptide Y. The novel compounds encompassed by the...
7067663 Triazolo pyrimidine compounds  
Pyrimidine compound (I) useful as a pharmaceutical intermediate, a process for preparing the pyrimidine compound (I), to intermediates used in the process, and use of the pyrimidine...
7034032 Cyclopentan-2-ol-1-yl-[1,2,3]triazolo[4,5-D]pyrimidine compounds  
The invention provides novel 1,2,3-triazolo[4,5-d]pyrimidine compounds, such as those represented by formula (I): their use as medicaments, particularly in platelet aggregation disorders,...
6974868 Compounds  
The invention provides new triazolo[4,5-d]pyrimidine compounds, their use as medicaments, compositions containing them and processes for their preparation.
6858616 Nitrogen containing heterobicycles as factor Xa inhibitors  
The present application describes nitrogen containing heterobicyclics and derivatives thereof, or pharmaceutically acceptable salt forms thereof, which are useful as inhibitors of factor Xa.
6844348 2,3,4-cyclopentan-2,3,4-triol-1-yl compounds  
The invention provides a compound of formula (I): wherein R 1 is alkyl C 1-6 or alkenyl C 2-6 , both independently optionally substituted by one or more groups selected from alkyl C 1-5 or...
6790841 2-hydroxymethylcyclopropylidenemethylpurines and -pyrimidines as antiviral agents  
Compounds which are active against viruses have the following Formulas: wherein B is a purine or pyrimidine heterocyclic ring and is preferably selected from the group consisting of...
6767910 Triazolo&lsqb 4,5-d&rsqb pyrimidinyl compounds  
Compounds of the formula (I) and their use as anti-platelet aggregation compounds.
6734180 NF-&kgr B inhibitor comprising an indan derivative as an active ingredient  
An inhibitor of NF-κB comprising as an active ingredient an indan derivative represented by the general formula (I) or a salt thereof.
6713483 &lsqb 1,2,3&rsqb -triazolo&lsqb 4,5-d&rsqb pyrimidine compounds  
The invention provides [1,2,3]-triazolo[4,5-d]pyrimidine analogue compounds of formula (I) The invention is also directed to pharmaceutical compositions containing the compounds, processes for...
6645965 Nitrate salts of antihypertensive medicines  
Nitric acid salts with medicines having an antihypertensive activity.
6635647 Decahydro-isoquinolines  
The invention provides compounds of formula (I) wherein A, B and R are as defined herein and the preparation thereof. The compounds of formula (I) are useful as somatostatin antagonists.
6525060 Triazolo(4,5-d)pyrimidine compounds  
Triazolo[4,5-d]pyrimidine compounds, their use as medicaments, compositions containing them and processes for their preparation. The compounds of the invention have the formula (I) as follows: ...
6525056 Heterocyclyl-substituted ring-fused pyridines and pyrimidines as corticotropin releasing hormone (CRH) antagonists, useful for treating cns and stress-related disorders  
Corticotropin releasing factor (CRF) antagonists of Formula (I): and their use in treating psychiatric disorders and neurological diseases, anxiety-related disorders, post-traumatic stress...
6458950 Compounds and pharmaceutical compositions containing the same  
A compound shown by the formula II, wherein Het is a mono- or polycyclic heterocyclic group comprising one or more hetero atoms selected from the group consisting of N, O and S which may be the...
6458796 Dihydro-&lsqb 1,2,3&rsqb triazolo-&lsqb 4,5-d&rsqb pyrimidin-7-one  
The present invention relates to novel dihydro-[1,2,3]triazolo-[4,5-d]pyrimidin-7-one, to processes for their preparation and to their use as medicaments, in particular as inhibitors of...
6455322 Competition binding assay for detecting P2YADP receptor ligands  
The invention provides a competition binding assay for detecting P2Y ADP receptor ligands.
6436945 Substituted O6-benzyl-8-aza-guanines  
The present invention provides AGT inactivating compounds, for example, substituted O 6 -benzyl-8-aza-guanines of the formula wherein R, for example, is pivaloyloxymethyl as well as...
6423716 Nitrogenous heterocyclic compounds  
The present invention relates to nitrogen-containing heterocyclic compounds represented by formula (I): wherein W represents 1,4-piperazinediyl, etc.; U represents NR 1 R 2 (wherein R 1 ...
6376667 Solid phase synthesis of heterocycles  
Methods and compounds for the synthesis of heterocycles, including pyrimidine-2,4-diones, are disclosed. Also disclosed are solid supports useful for solid phase synthesis, and methods for making...
6369064 Triazolo(4,5-d)pyrimidine compounds  
Triazolo[4,5-d]pyrimidine compounds are provided of the formula (I) wherein R 1 , R 2 , R 3 , R 4 , R 5 and R 6 are as defined in the specification. Compositions containing the compounds are...
6297232 Triazolo[4,5-D]pyrimidinyl derivatives and their use as medicaments  
The invention relates to triazolo[4,5-d]pyrimidin-3-yl derivatives which are useful in the treatment of platelet aggregation disorders.
6251910 1,2,3-triazolo[4,5-d]pyrimidines as P2T receptor antagonists  
Compounds of formula having the following stereochemistry ##STR1## wherein R, R 1 , R 2 , R 3 and R 4 are as defined in the specification. The compounds are useful as P 2T receptor antagonists.
RE37234 Nitrosated and nitrosylated phosphodiestrase inhibitor compounds, compositions and their uses  
Disclosed are nitrosated and/or nitrosylated phosphodiesterase inhibitors having the formula NO n -PDE inhibitor where n is 1 or 2. The invention also provides compositions comprising such...
6165942 Heterocycle-fused pyrimidinone derivative and herbicidal composition  
A compound represented by the general formula (I) and a salt thereof: ##STR1## wherein: Rf represents a (C 1 -C 4 )haloalkyl group; X.about.Y represents NN or CHN or the like; A represents a...
6156766 Benzamide compounds and pharmaceutical use thereof  
Benzamide compounds of the formula ##STR1## wherein each symbol is defined in the specification, isomers thereof and pharmaceutically acceptable acid addition salts thereof. Pharmaceutical...
6156756 Triazolo [4,5-d]pyrimidine compounds, their use as medicaments, compositions containing them and processes for their preparation  
The invention provides new triazolo[4,5-d]pyrimidine compounds, their use as medicaments, compositions containing them and processes for their preparation.
6124300 Aryloxy- and arylthio- fused pyridines and pyrimidines and derivatives  
Novel compounds and pharmaceutical compositions thereof, and methods of using same in treating anxiety, depression, and other psychiatric and neurological disorders. The novel compounds provided by...
6107300 Arylamino fused pyrimidines  
Corticotropin releasing factor (CRF) antagonists of formula I or formula II: ##STR1## and their use in treating anxiety, depression, and other psychiatric and neurological disorders.
6046207 Benzopyranopyrrole and benzopyranopyridine α-1 adrenergic compounds  
The present invention relates to a compound of the formula and the pharmaceutically acceptable salts thereof wherein W is a bicyclic heterocyclic ring system. The compounds are α-1 adrenergic...
6030973 Heterocyclic compounds having antidiabetic hypolipidemia and antihypertensive properties, process for their preparation and pharmaceutical compositions containing them  
The present invention relates to novel antidiabetic compounds, their tautomeric forms, their derivatives, their analogues, their stereoisomers, their polymorphs, their pharmaceutically acceptable...
5962684 Method of preparation of dideoxycarbocyclic nucleosides  
A therapeutic method is provided, employing an antiviral compound of the general formula: ##STR1## wherein Z is H, OR' or N(R) 2 , wherein R' is H, (C 1 -C 4 )alkyl, aryl, CHO, (C 1 -C 16...
5929079 Trans cyclopentanyl azaadenyl analogs useful as immunosuppressants  
This invention relates to Trans cyclopentanyl purine analogs of the formula (1) ##STR1## wherein the substituent in the 3-position on the cyclopentanyl ring is in the Trans configuration relative...
5880129 Methods of inhibiting invasion and metastasis of malignant solid tumors  
A discovery underlying this invention is the concordance between particular cellular signaling mechanisms and cancer cell growth and metastasis. It has now been discovered that certain compounds...
5869659 Heteroatom-containing cyclopentanopyridyl-oxazolidinones  
The present invention relates to heteroatom-containing cyclopentanopyridyl-oxazolidinones, processes for their preparation and their use as medicaments, in particular as antibacterial medicaments.
5807854 Pyrimidone derivatives with antifungal activity  
Compounds of general formula I and their salts and solvates are antifungal agents and as such are useful in the treatment of various fungal infections. Pharmaceutical compositions including these...
5763608 Process for preparing pyrimidine derivatives  
The present invention provides a process for preparing a 5,6-dihydro-3H-pyrimidin-4-one derivatives which comprises the steps of (a) dehydrating a N-acyl beta amino acid in the presence of a...
5747496 Inhibitors of platelet aggregation  
Compounds of the formula (I) ##STR1## wherein B is O or CH 2 ; X is selected from NR 1 R 2 , SR 1 , and C 1 -C 7 alkyl; Y is selected SR 1 , NR 1 R 2 , and C 1 -C 7 alkyl; R 1 and...
Matches 1 - 50 out of 116 1 2 3 >